JPM jump-starts 2019

Gainers, decliners in the wake of the 2019 J.P. Morgan Healthcare Conference

About three quarters of the more than 200 biopharma companies presenting at the 2019 J.P. Morgan Healthcare Conference saw their stock prices rise last week.

Leading the pack was the 53% jump by Insmed Inc. (NASDAQ:INSM), which announced

Read the full 376 word article

User Sign In